Award
Delivery Order #SPE2DR26FAWWF
AmerisourceBergen Awarded Delivery Order for Antiretroviral Medication
Buyer
Defense Logistics Agency
Award Amount
$15,909.69
Ceiling
$15,909.69
Awarded
March 16, 2026
Period of Performance
Mar 16, 2026 – Mar 17, 2026
Identifier
SPE2DR26FAWWF
NAICS
325411
This award represents a delivery order contract issued under a broader indefinite delivery vehicle held by AmerisourceBergen Drug Corp, a leading pharmaceutical services provider. The contract involves the procurement of ATRIPLA tablets, an essential antiretroviral medication used in HIV treatment, highlighting the importance of ensuring timely access to critical pharmaceuticals. The work encompasses the supply and distribution of the medication, supporting healthcare programs and patient treatment regimens. This delivery order is part of a multi-year IDV contract that AmerisourceBergen holds for European procurement, underscoring the company's pivotal role in managing complex pharmaceutical supply chains across multiple regions. The contract was awarded within a competitive framework facilitated by the existing vehicle. The performance period is brief and specific, spanning a recent short-term timeframe, indicating a targeted procurement to fulfill immediate healthcare needs.
Description
4571156708!ATRIPLA TABLET 30S